Interleukin-23 Antagonist
7 drugs across 2 manufacturers|0 Generic,7 Brand
Total Drugs
7
0G / 7B
Manufacturers
2
Avg $20324.5691/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
7 flat
of 7 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STELARA 45 MG/0.5 ML SYRINGE ustekinumab | $29841.6480 per ML | — |
STELARA 90 MG/ML SYRINGE ustekinumab | $29794.5447 per ML | — |
SKYRIZI 150 MG/ML SYRINGE risankizumab-rzaa | $22942.3716 per ML | — |
SKYRIZI 150 MG/ML PEN risankizumab-rzaa | $22807.6858 per ML | — |
TREMFYA 100 MG/ML SYRINGE Guselkumab | $14769.7353 per ML | — |
TREMFYA 100 MG/ML ONE-PRESS Guselkumab | $14766.3280 per ML | — |
TREMFYA 200 MG/2 ML PEN guselkumab | $7349.6703 per ML | — |